Risedronic acid
Risedronic Acid
Risedronic acid (pronounced ri-SE-dro-nic acid), also known as risedronate, is a type of medication used to treat and prevent osteoporosis, Paget's disease of bone, and other conditions that cause the body to lose too much bone.
Pronunciation
Risedronic acid is pronounced as ri-SE-dro-nic acid.
Etymology
The term "Risedronic acid" is derived from its chemical name, [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid]. The "risedron" part of the name is a blend of parts of the chemical name, while the "-ic acid" suffix indicates that it is an acid.
Usage
Risedronic acid is a type of Bisphosphonate, a class of drugs that prevent the loss of bone density. It works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Risedronic acid is used to treat and prevent osteoporosis, a condition in which the bones become thin and weak and break easily. It is also used to treat Paget's disease of bone, a condition in which the bones are soft, weak, and may be deformed, painful, or easily broken.
Related Terms
- Bisphosphonate: A class of drugs that prevent the loss of bone density.
- Osteoporosis: A condition in which the bones become thin and weak and break easily.
- Paget's disease of bone: A condition in which the bones are soft, weak, and may be deformed, painful, or easily broken.
External links
- Medical encyclopedia article on Risedronic acid
- Wikipedia's article - Risedronic acid
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski